Company Performance Metrics
- Robert Whalen: CSO
Altravax was incorporated in 2009 and is a privately held biopharmaceutical company based in North Dakota with research facilities in Sunnyvale, California. The Company is focused on the discovery and development of novel products to fight infectious diseases and other conditions. Our proprietary Immunogen Optimization System™ (IOS) offers unique
opportunities to create novel vaccines or improve currently available alternatives to fill unmet medical needs. The Company has a robust pipeline of candidates at various stages of development, including a therapeutic vaccine against chronic hepatitis B infection and a preventive vaccine against all four dengue virus. Altravax seeks strategic alliances to develop these lead candidates for clinical testing.
